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license (http://creativebased instrument to assess instrumental activities of daily living (IADL) during the course of demen-
tia: the Amsterdam IADL Questionnaire (A-IADL-Q).
Methods: Participants (n5 102)were patients and their informantswho visited theAlzheimer Center
of the VU University Medical Center. Linear mixed models with random effects were used to relate
longitudinal change on the A-IADL-Q to diagnosis and to longitudinal change in cognitive measures.
Results: We found longitudinal change on the A-IADL-Q to differ between diagnosis (P 5 .003),
with dementia patients showing the fastest rate of decline (P, .001). In addition, we found longitu-
dinal change on the A-IADL-Q to be related to longitudinal change in cognitive measures (global
cognition: P , .001; memory: P 5 .024; executive functioning: P 5 .028).
Discussion: Findings indicate the A-IADL-Q is sensitive to change over time in IADL functioning
and can be used in evaluating treatment effects and assessing individual disease progress.
 2015 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
3.0/).Keywords: Instrumental activities of daily living; Dementia; Alzheimer’s disease; Mild cognitive impairment; Subjectivecognitive decline; Responsiveness1. Introduction
Dementia is characterized by progressive cognitive
decline and problems in performing instrumental activities
of daily living (IADL) [1]. IADL are complex activities
that are necessary to function independently, e.g. cooking
[2]. Unfortunately, most of the questionnaires that measure
IADL are not up-to-date and lack information about impor-
tant measurement properties [3]. Therefore, Sikkes et al. [4]
has developed the informant-based Amsterdam IADL Ques-
tionnairea, which has shown to be a reliable and valid
instrument in the evaluation of dementia [4,5].thor. Tel.: 131-20440685; Fax: 131-204448529.
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commons.org/licenses/by-nc-nd/3.0/).An important property of questionnaires that measure pa-
tient reported or informant-based outcomes is the instru-
ments’ ability to measure change over time [6]. This
property, described as “sensitivity to change” or “respon-
siveness”, is considered an aspect of validity. In assessing
IADL, measuring change is highly important because it en-
ables clinicians to monitor disease progress of their patients
and it enables the evaluation of potential treatment effects
[7]. The longitudinal validity of the Amsterdam IADLQues-
tionnaire (A-IADL-Q) is not yet known.
Themain purpose of this study is to assess the ability of the
A-IADL-Q to measure change in IADL functioning over
time. To date, no gold standard for measuring change in
IADL functioning is available. Therefore, the recommended
approach to assess responsiveness is by construct validation
[8]. Construct validity refers to the degree towhich change in
the scores on a measurement instrument is consistent with aimer’s Association. This is an open access article under the CC BY-NC-ND
N. Koster et al. / Alzheimer’s & Dementia 11 (2015) 1231-12401232priori formulated hypotheses [8]. Consequently, in this case
these hypotheses should concern the relationship between
change in scores on the A-IADL-Q and change indicated
by other important indicators for change in daily functioning.
Using this approach, we first related longitudinal
A-IADL-Q scores to diagnosis. We hypothesize that change
on the A-IADL-Q differs between patients with a diagnosis
of dementia, subjective memory complaints (SMC), and
mild cognitive impairment (MCI). Because dementia is
characterized by progressive decline while MCI patients
and healthy elderly usually show only gradual or no decline,
we expect the dementia group to show a more rapid rate of
decline compared with the MCI and the SMC group.
Second, many studies reported an association between
IADL functioning and cognitive decline. Early work on this
relationship already demonstrated global cognitive func-
tioning to be related to IADL functioning [9]. More recent
studies assessing the relationship between IADL functioning
and specific cognitive domains show attention/executive func-
tioning [10–12] and memory to be the two most consistently
associated domains [13,14]. Based on these studies and
because global cognition, memory, and attention/executive
functioning are distinct cognitive constructs from a clinical
perspective, we assessed the longitudinal relationship
between IADL functioning and these three constructs
separately. We hypothesize that change over time in
A-IADL-Q scores is related to change over time in global
cognition, memory, and attention/executive functioning.2. Method
2.1. Participants
Participants in this study were patients and their infor-
mants who visited the Alzheimer Center of the VU Univer-
sity Medical Center for dementia screening between January
2012 and December 2012 and for follow up between
December 2012 and May 2013.
Patients were excluded when their cognitive decline was
due to other prominent medical conditions and when there
were less than 6 months between baseline and follow-upmea-
surements. In addition, for the relationship of the A-IADL-Q
with diagnosis, patients who converted to dementia during
the study were excluded to ensure homogeneity of groups.
Also, patients who had more than 4 months in between the
follow-up measurements of IADL and cognition were
excluded for the analyses concerning, because change could
have occurred. Informed consent was obtained from all pa-
tients and informants. The study was approved by theMedical
Ethical Committee of the VU University Medical Center.
2.2. MeasuresbMore detailed information on the measurement properties of the neuro-
psychological tests and the included subscores can be found in the web-only
Supplemental Material.2.2.1. Dementia screening
All patients underwent a dementia screening at baseline.
All dementia diagnoses were based on the consensus criteriafor the different types of dementia [15–18]. MCI was
diagnosed according to Petersen criteria [19]. Patients who
did not meet the criteria for dementia or MCI and did not
have other neurological impairments were classified as
“subjective memory complaints” (SMC).
2.2.2. Amsterdam IADL questionnaire
The A-IADL-Q is a computerized questionnaire aimed at
measuring difficulties with complex daily activities. It is
self-administered, completed by an informant of the patient.
The A-IADL-Q consists of 70 items and for each item diffi-
culty is rated on a 5-point scale. To optimize individual dif-
ferences in premorbid IADL activities, items are tailored to
individual responses (Fig. 1) [4]. When the patient did not
perform the main activity more detailed items on this activ-
ity were skipped. The total score is calculated using an item
response theory (IRT) method of scoring. IRT assumes that
ordered-categorical item responses represent an underlying
construct [20,21]. In this case, the construct is IADL
functioning, ranging from disability to ability. The total
score is normally distributed (M 5 50, SD 5 10), with
higher scores indicating better functioning [5]. Good
construct validity, good content validity, high internal con-
sistency (IRT reliability coefficient: .97), and high test-
retest reliability (87.9% of the items had kappa values
..60) were demonstrated previously [4,5].
2.2.3. Cognitionb
Global cognitive ability was measured by the Mini-
Mental State Examination (MMSE), a brief interview
schedule that is widely used as a screening test for dementia
[22,23].
To capture the complete domain of memory functioning,
three widely used tests that measure different aspects of
memory were selected. The following paper-and-pencil tests
were administered: the Dutch version of the Rey Auditory
Verbal Learning Task (RAVLT) [24] that measures verbal
learning and memory, the Visual Association Task (VAT)
that is a brief learning task based on imagery mnemonics
[25], and the Digit Span task of the Wechsler Adult Intelli-
gence Scale III. This task comprises Digits Forward and
Digits Backward, measuring immediate recall and working
memory, respectively [26]. Both tests consist of digit se-
quences that need to be repeated by the patient, either in for-
ward or in backward order.
To capture the complete domain of attention/executive
functioning, three widely used tests that measure different
aspects of executive functioning were selected. The
following paper-and-pencil timed tests were administered:
the Stroop Color-Word Task, which measures cognitive flex-
ibility and sensitivity to interference [26], the Trail Making
Test (TMT) A and B, which measures attention and
Fig. 1. Example of an item of the A-IADL-Q. Abbreviation: IADL, instrumental activities of daily living; A-IADL-Q, Amsterdam IADL Questionnaire.
N. Koster et al. / Alzheimer’s & Dementia 11 (2015) 1231-1240 1233cognitive flexibility/set shifting [26], and the Dutch version
of the Letter Fluency of the Controlled Oral Word Associa-
tion Test measuring verbal fluency, which is part of execu-
tive functioning [26,27].2.3. Procedure
Measurements were obtained at baseline and follow-up.
The amount of time between baseline and follow-up varied
per subject, with a minimum of 6 months. During the base-
line visit to the Alzheimer Center patients underwent a stan-
dardized dementia screening, while the informant completed
the A-IADL-Q. A research assistant provided instructions
and stayed available to answer questions if needed.
At follow-up, patients were recruited at their extensive
follow-up meeting, their appointment with a neurologist,
via telephone, or via e-mail. Patients recruited at the center
underwent a cognitive assessment, while the informant
completed the A-IADL-Q. Patients recruited via telephone
or email were requested to complete the A-IADL-Q elec-
tronically from home. This approach was also used when in-
formants were not available at follow-up.2.4. Statistical analyses
Sociodemographic factors of all participants were exam-
ined and differences between diagnostic groups were tested
using Pearson’s chi square, Fisher’s exact test, or indepen-
dent ANOVAwith post hoc procedures if appropriate.
To test our first hypothesis, the relationship between diag-
nosis and our longitudinal A-IADL-Q data were assessed us-
ing a linear mixed model with random effects. Linear mixedmodels incorporate a random intercept and a random slope,
which allows for individual variability in initial A-IADL-Q
scores and the rate of decline in A-IADL-Q scores [28]. The
interaction between diagnosis and time represented the rela-
tionship between diagnosis and change in A-IADL-Q scores
over time.
To test our second hypothesis, we examined the relation-
ship between IADL and our three cognitive constructs:
global cognition, memory and attention/executive func-
tioning. Memory and attention/executive functioning were
assessed using several neuropsychological tests, which
cannot be directly compared with each other. Therefore,
CFAwith strict factorial invariance, suitable for longitudinal
data, was used to derive one score (the latent variable) from
these different tests to represent the cognitive domain.
Detailed information on this method can be found in
Oort [29] and Oort et al. [30]. We assessed overall
goodness-of-fit using the maximum likelihood estimation
method. A satisfactory goodness-of-fit is indicated by the
magnitude of the following fit indices: a nonsignificant chi
square test, the comparative fit index (CFI) . .95, the root
mean square error of approximation (RMSEA) , .06, and
the standardized root mean square residual (SRMR) , .08
[31]. In summary, for each cognitive domain, we performed
CFA to derive one latent score that represented this domain.
To be able to use this score as a good representative, a one-
factor model with satisfactory fit indices needed to be
confirmed.
After this, the longitudinal relationship between change
in the three constructs and change in IADL ratings was
analyzed by linear mixed models. Also, we incorporated
the cross-sectional effect to assess baseline relationships.
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decline in A-IADL-Q score over time for all three cognitive
constructs.
All models were corrected for age of the patient at base-
line, gender and education level [32,33]. Statistical analyses
were performed using SPSS version 20.0 for Windows
(SPSS Inc., Chicago, IL) and Mplus. The significance
level was set at P , .05.3. Results
Fig. 2 shows the subject flow from baseline to follow-up.
A total of 208 persons were eligible for inclusion, of which
102 actually participated in the study. Main reasons for drop-
out were untraceable informants, the baseline informant not
being available at follow-up, and refusal of the patient or
informant and nonresponse. Mean time between baseline
and follow-up was 1.6 years (SD 5 0.9).
Table 1 presents baseline patient and informant character-
istics of the total sample and of the diagnosis groups SMC,
MCI, and dementia. We found no significant differences in
patient characteristics between groups. Age of the infor-
mants differed between groups F(2,87) 5 4.41, P 5 .024,
but was not significantly different on post hoc testing. Over-
all, most informants were spouses of the patient; however,Fig. 2. Subject flow from baseline to follothere was a slight difference between groups (P 5 .021).
Mean IADL score for the total sample at baseline was 51.0
(SD 5 15.7) and 42.8 (SD 5 20.2) at follow-up.3.1. Differences between diagnoses in change over time on
the A-IADL-Q
For this analysis, subjects who converted fromMCI to de-
mentia (n 5 5) and participants with another diagnosis than
dementia, MCI, or SMC (n5 10) were excluded. The mean
IADL scores for these different groups were for the SMC
group 64.2 (SD 5 11.7) at baseline and 64.0 (SD 5 16.2)
at follow-up. For the stable MCI group, the mean IADL
score was 58.9 (SD 5 10.7) at baseline and 57.4
(SD 5 12.7) at follow-up. Patients with a diagnosis of de-
mentia had a mean baseline IADL score of 44.8
(SD 5 15.6) and a mean score of 34.0 (SD 5 16.8) at
follow-up.
Linear mixed modeling showed that the interaction be-
tween diagnosis and time, which models the relationship be-
tween diagnosis and change in A-IADL-Q scores over time,
was found to be significant (P 5 .003). As illustrated in
Fig. 3, this means that the rate of decline in A-IADL-Q
scores differed between diagnoses. The A-IADL-Q score
of the dementia group declined with a rate of 7.35 pointsw-up. Abbreviation: FU, follow-up.
Table 1
Baseline patient and informant characteristics and comparison between diagnosis groups
Patients (n 5 102) Informants (n 5 102)
SMC
(n 5 12)
MCI
(n 5 23)
Dementia
(n 5 57) P-value
SMC
(n 5 12)
MCI
(n 5 23)
Dementia
(n 5 57) P-value
Age 65 (7) 61 (7) 66 (8) 66 (7) .120 61 (52-70)z 52 (15) 60 (9){ 64 (7)x .024
Female gender 36 (35.3%) 3 (25%) 7 (30.4%) 23 (40.4%) .489 67 (65.7%) 9 (75.0%) 17 (73.9%) 34 (59.6%) .374
Level of education* 5 (4–6)y 5 (4–6) 5 (3.5–6) 5 (4–6)x .096
Relationship is spouse 92 (90.2%) 9 (75.0%) 20 (87.1%) 53 (93.0%) .021
Duration relationship,
P . 10 years
99 (97.1%)y 12 (100%) 23 (100%) 55 (98.2 %)x 1
Living together with
patient
93 (91.2%)y 10 (83.3%) 20 (87.0%) 53 (93.0%)x .249
Abbreviations: SMC, subjective memory complaints; MCI, mild cognitive impairment.
NOTE. Data are presented as mean (SD), median (interquartile range), or n (%). The diagnosis group labeled as ‘other’ (n 5 10) is included in the charac-
teristics for the total sample, but not presented separately. Differences between groups were tested using independent analysis of variance, Pearson’s chi square,
or Fisher’s exact test.
*Education according to Verhage’s classification, ranging from 1 (low) to 7 (high) [41].
yn 5 101.
zn 5 100.
xn 5 56.
{n 5 22.
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This was significantly faster compared with the rate
of decline in the SMC and the MCI groups (P 5 .007)
(Fig. 3). Also, we found an effect of diagnosis on
A-IADL-Q scores (P , .001) and of time (P 5 .010) on
A-IADL-Q scores.3.2. Relationship between change in A-IADL-Q scores and
change in cognition
Two subjects were excluded because more than 4 months
passed by between IADL and cognitive follow-up measures
being taken, bringing the sample size to 100.
Results of linear mixed modeling showed a longitudinal
effect of MMSE on change in IADL scores over time
(P , .001). The rate of decline in MMSE score was related
to the rate of decline in IADL score. As shown in Table 2, a
decrease of one point on the MMSE was associated with a
decrease of 3.11 points on the A-IADL-Q. Also, we found
a cross-sectional effect: a lower baseline MMSE score was
associated with a lower score on the A-IADL-Q (P , .001).
Fig. 4 illustrates the relationship between individual tra-
jectories of the A-IADL-Q score over time and change in
MMSE score. To depict this relationship, we arranged sub-
jects into quartiles of change in MMSE score. The trajec-
tories of subjects in the first quartile, with the largest
amount of decline on the MMSE, suggest decreasing
IADL scores over time. Those in the fourth quartile
improved on the MMSE and, although there is individual
variability, their trajectories suggest stability or even a slight
increase of IADL scores over time.
To test the relationship between change in IADL and
change in memory functioning we used CFA to construct
one score that represented scores on the three different neu-
ropsychological measures. It was assumed that the distribu-tion of this new memory scale was standard normal (M5 0,
SD5 1). Three subjects had missing values for all measures
and were therefore excluded bringing the sample size to 97.
As described, we used the fit indices of the chi-square test,
CFI, RMSEA, and SRMR to assess goodness-of-fit. CFA
showed that a model including all memory tests did not
have satisfactory fit indices and did not show to measure
one underlying factor (latent variable). We therefore subse-
quently explored different combinations of memory tests
subscores to construct a model that satisfied both criteria.
This led us to the final model incorporating “total score of
the RAVLT”, “VAT A total score”, and “Digit Span back-
wards total score”. Models that also included one of the other
variables (delayed recall of the RAVLT, VAT B and Digit
Span forwards) did not show a one-factor model or had un-
satisfactory fit indices. Of the final model, the SRMR was
slightly too high (SRMR 5 .108), but the other fit indices
indicate a satisfactory fit: CFI 5 .978, RMSEA 5 .033,
c2(17) 5 18.77, P 5 .342. Detailed information on model
parameters can be found online in the Supplemental
Material.
After this, we assessed the longitudinal relationship be-
tween memory and A-IADL-Q scores. As shown in
Table 2, we found a longitudinal effect of memory on
change in IADL score over time. A decline in memory
was significantly related to a decline in IADL score over
time (P 5 .024). A decline of one point on the memory
scale was associated with a decline of 7.6 points on the
A-IADL-Q. Also, we found a cross-sectional effect of
memory on IADL score, indicating that a lower baseline
memory score was related to a lower IADL score
(P , .001).
To test the relationship between our longitudinal IADL
and the executive functioning domain, we used the same pro-
cedure as for the memory domain. We explored several
Fig. 3. Change in A-IADL-Q scores over time for the subjective memory complaints, mild cognitive impairment and dementia groups, n5 87. Time is in years
with zero representing the time of the baseline screening. Abbreviation: IADL, instrumental activities of daily living; A-IADL-Q, Amsterdam IADL
Questionnaire.
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tioning tests to construct a model that measured only one un-
derlying factor and also provided a good fit to the data.Table 2
Cross-sectional and longitudinal relationships between the MMSE,
memory, and executive functioning and scores on the A-IADL-Q
B (SE) 95% CI Stand. B P-value
MMSE (n 5 100)
Cross-sectional 1.80 (0.37) [1.06, 2.53] .004 ,.001
Longitudinal 3.11 (0.72) [1.68, 4.55] .01 ,.001
Memory (n 5 97)
Cross-sectional 13.37 (1.30) [10.8, 15.92] .11 ,.001
Longitudinal 7.59 (3.37) [0.99, 14.20] .14 .024
Executive functioning (n 5 54)
Cross-sectional 22.85 (0.91) [24.68, 21.03] 2.02 .003
Longitudinal 23.81 (1.68) [27.18, 20.44] 2.05 .028
Abbreviations: MMSE, Mini-Mental State Examination; SE, standard er-
ror; Stand. B, standardized B; CI, confidence interval.
NOTE. B parameters are unstandardized. Standardized Bs are based on
standardized B5 B ! SD(Xi)/SD(Y), with X as independent variable and
Yas dependent variable, SD5 SE/O(n). For theMMSE andmemory, higher
scores indicate better performance, for executive functioning a lower score
indicates better performance. Executive functioning is measured by Trail
Making Test B, where performance is given by the amount of minutes
required for completion.However, it was not possible to construct a model that satis-
fied both criteria.
To provide at least a rough indication of the relationship
we aimed to assess, we used data of the TMT B, which mea-
sures executive functioning. Attention was therefore not as-
sessed. Because 48 patients did not complete the TMT B,
sample size was 54. Using linear mixed modeling with
random effects, we found a longitudinal effect of change
in executive functioning on change in IADL score,
F(1,57.24) 5 5.12, P 5 .028. An increase of one minute of
time spent on the TMT B is associated with a decline of
3.81 points on the A-IADL-Q (Table 2). In addition, we
found a cross-sectional effect of executive functioning on
IADL score (P 5 .003). A higher amount of time spent on
the TMT B is associated with a lower score on the
A-IADL-Q.4. Discussion
In this longitudinal validation study, we confirmed that
change in scores on the A-IADL-Q over time differed be-
tween diagnoses, with the most rapid IADL decline in pa-
tients with dementia. Also, we confirmed that decline in
scores on the A-IADL-Q was related to decline in global
cognition, memory, and executive functioning.
Fig. 4. Individual trajectories of the A-IADL-Q score over time by quartiles of change inMMSE score. Differences in MMSE score from baseline to follow-up:
quartile 1 (n 5 12) 28 to 23; quartile 2 (n 5 14) 22 to 21; quartile 3 (n 5 10) 0 to 1; quartile 4 (n 5 10) 2 to 4. Abbreviations: MMSE, Mini-Mental State
Examination; IADL, instrumental activities of daily living; A-IADL-Q, Amsterdam IADL Questionnaire.
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where good construct validity, good content validity, and
high internal consistency were demonstrated, this is the
first study on the sensitivity to change of the A-IADL-Q.
Also, this is the first study to assess the responsiveness of
an IADL instrument by the construct approach, which is
the recommended approach in the absence of a gold
standard [8]. The ability of other IADL questionnaires to
measure change over time has been reviewed by Sikkes
et al. [3]. They state that for most instruments, adequate psy-
chometric information to rate responsiveness is lacking. To
our knowledge, only one study directly addressed the sensi-
tivity to change of an IADL instrument [34]. However, the
authors used a global impression of change given by a clini-
cian as a gold standard to define the sensitivity and speci-ficity of the instrument. Besides that, they only provided
correlations between change scores on the IADL question-
naire and cognitive measures instead of using linear mixed
models [35]. Because there is no gold standard for change
in IADL, it might be questioned whether the results in this
study are specific enough to draw conclusions on the ques-
tionnaire’s sensitivity to change in IADL functioning.
Our findings showed that the A-IADL-Qwas able to mea-
sure change in IADL functioning. First, we demonstrated
that dementia patients showed a faster rate of decline in
A-IADL-Q score over time compared with MCI and SMC
patients. This longitudinal relationship between diagnosis
and change in IADL scores was addressed in only a few
other studies. One study by Farias et al. [36] was aimed at
assessing the longitudinal relationship between change in
N. Koster et al. / Alzheimer’s & Dementia 11 (2015) 1231-12401238IADL and change in cognition. Comparable with our results,
they found that the annual rate of IADL change differed be-
tween cognitively normal individuals, MCI patients and pa-
tients with dementia, with the last group showing the fastest
rate of decline [36]. An interesting finding in our study is the
individual variability in the MCI and SMC groups. Based on
previous findings it is anticipated that part of the MCI pa-
tients will convert to dementia over time [37]. Possibly, pa-
tients in the SMC and MCI group who show a rapid rate of
IADL decline are the patients who will convert to dementia
in the future.
Second, we demonstrated that change in A-IADL-Q
score was related to change in global cognition, memory,
and executive functioning. For the composition of the cogni-
tive domains, we encountered problems in deriving one
score from the different neuropsychological tests, possibly
due to unsatisfactory psychometric properties of the used in-
strumentsb. Previous comparable studies only assessed how
a cognitive domain measured at baseline could predict
decline in functional ability [11,12]. One study that also
specifically examined the longitudinal relationship
between change in cognition and change in IADL
functioning is the study by Farias et al. [36]. In line with
our results, the authors demonstrated a relationship between
change in IADL functioning and change in memory and ex-
ecutive functioning. These results support the possibility of
measuring changes in the construct IADL over time.
The following limitations should be taken into account.
First, subjects with a dementia diagnosis were overrepre-
sented in our sample, probably due to selection bias. How-
ever, our MCI and SMC groups behaved as expected based
on clinical prognosis and we can therefore assume that our
results are representative for the different groups. Another
potential limitation could be that we treated follow-up
IADL and cognitive measures that were taken at different
moments in time as if they were measured on the same
date. Although we limited time difference to 4 months, a
change in functioning could have occurred between the
two measurements. Yet, this would have only underesti-
mated the relationship between the trajectory of change
in cognition and the trajectory of change in IADL. Because
we did find a significant relationship between IADL and
cognition, we feel even more confident in the robustness
of this finding. Third, in this study the mood of the patient
and informant, which could potentially have an effect on
measures of daily functioning, was not assessed. However,
a previous study by Sikkes et al. [5] showed the correlation
of the A-IADL-Q with depressive symptoms of both the pa-
tient and the informant to be low. Therefore, do not expect
these factors to have a significant influence on A-IADL-Q
scores in this study.
The main strength of this study is that, to our knowl-
edge, this is the first study to assess the sensitivity to
change of an IADL instrument by the construct approach.
In the absence of a gold standard, this is the recommended
method to assess responsiveness [8]. It provides additionalproof that a true change in IADL is measured. Another
strength is that this study addressed the relationship over
time of the A-IADL-Q with several different longitudinal
measures. The fact that the A-IADL-Q showed to be sensi-
tive to changes in all of those measures underlines the abil-
ity of the A-IADL-Q to measure change over time.
Furthermore, we included not only patients with dementia
to assess responsiveness, but also individuals with MCI and
SMC. This strengthens the generalizability of the results to
a memory clinic setting and suggests that the A-IADL-Q
could be applicable as a measure in broader populations
as well.
Assessing changes in functional ability over time is
essential for intervention studies because functional mea-
sures are directly related to caregiver burden [38] and are
of specific relevance to the quality of life of the patient
[39]. Additionally, they show less learning effects compared
with cognitive ones [38] and results are less influenced by
education, gender, and age [40]. Therefore, the A-IADL-Q
can be of great relevance as an outcome measure in future
randomized clinical trials using various approaches and
may be of more use than other IADL instruments where
the responsiveness has not been supported [3]. Besides the
use in intervention studies, it can be a highly useful instru-
ment for clinicians to assess disease progression and deteri-
oration in the ability to perform daily activities of their
patients in early and later stages of dementia.
In conclusion, in this longitudinal validation study of the
A-IADL-Q, we demonstrated the sensitivity to changes of
the A-IADL-Q. The results indicate that the A-IADL-Q
may be a useful tool for evaluating treatment effects and
for assessing individual disease progress. Future research
could investigate whether sensitivity to change is observed
equally in all items of the A-IADL-Q. Also because valida-
tion of a questionnaire is an ongoing process, future studies
should examine the responsiveness of the A-IADL-Q in
other clinical or cultural populations. In addition, further
research on the longitudinal relationship of the A-IADL-Q
with biomarkers of Alzheimer’s disease pathology could
take the longitudinal validation of the A-IADL-Q to a next
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1. Systematic review: Recently, the Amsterdam IADL
Questionnaire (A-IADL-Q) was developed, aimed
at assessing instrumental activities of daily living
(IADL) during the course of dementia. Studies
showed this questionnaire to be a reliable and valid
instrument in the evaluation of dementia. In assess-
ing IADL, measuring change is highly important
for the monitoring of individual disease progress
and the evaluation of potential treatment effects.
This is the first study aimed at investigating the sensi-
tivity to change of the A-IADL-Q.
2. Interpretation: Our findings demonstrate the sensi-
tivity to changes of the A-IADL-Q, which indicates
the A-IADL-Q may be a useful tool in assessing
IADL functioning over time. Also, this is one of
the first studies to assess the sensitivity to change
of an IADL instrument.
3. Future directions: The sensitivity to change of the A-
IADL-Qcould beexamined inother clinical or cultural
populations. Also, further research could focus on the
longitudinal relationship of the A-IADL-Q with bio-
markers of Alzheimer’s disease pathology.References
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